• 1
    US Preventive Health Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Alexandria, Va: International Medical Publishing; 1996.
  • 2
    Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology. 1997;112: 594 642.
  • 3
    Mandel J, Bond J, Church T, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365 71.
  • 4
    Kronborg O, Fenger C, Olsen J, Jorgensen D, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467 71.
  • 5
    Hardcastle J, Chamberlain J, Robinson M, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472 7.
  • 6
    Selby J, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653 7.
  • 7
    Centers for Disease Control and Prevention. Screening for colon cancer. MMWR. 1996;45:107 10.
  • 8
    Pignone M, Harris R, Kinsinger L. Changing cancer screening practice: physician or patient activation? J Gen Intern Med. 1997; 14(Suppl 1):110.
  • 9
    Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? Soc Sci Med. 1997;44:681 92.
  • 10
    Coulter A, Entwhistle V, Gilbert D. Sharing decisions with patients: is the information good enough? BMJ. 1999;318:318 22.
  • 11
    Greenfield S, Kaplan S, Ware J, Yano E, Frank H. Patients' participation in medical care: effects on blood sugar control and quality of life in diabetes. J Gen Intern Med. 1988;3:448 57.
  • 12
    Flood A, Wennberg JE, Nease RF, Fowler FJ, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer. J Gen Intern Med. 1996;11:342 9.
  • 13
    Leard L, Savides T, Ganiats T. Patient preferences for colorectal cancer screening. J Fam Pract. 1997;45:211 8.